Azzad Asset Management Inc. ADV lessened its stake in National Research Co. (NASDAQ:NRC – Free Report) by 18.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,481 shares of the company’s stock after selling 4,609 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in National Research were worth $470,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in National Research by 184.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after acquiring an additional 2,061 shares during the last quarter. Gladius Capital Management LP grew its position in shares of National Research by 59.8% during the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after purchasing an additional 496 shares in the last quarter. Teacher Retirement System of Texas increased its holdings in shares of National Research by 54.4% in the fourth quarter. Teacher Retirement System of Texas now owns 11,637 shares of the company’s stock worth $460,000 after purchasing an additional 4,102 shares during the last quarter. BNP Paribas Financial Markets lifted its position in shares of National Research by 22.3% in the fourth quarter. BNP Paribas Financial Markets now owns 11,479 shares of the company’s stock worth $454,000 after buying an additional 2,095 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in National Research by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock valued at $25,176,000 after buying an additional 7,531 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.
National Research Stock Performance
NASDAQ NRC opened at $22.80 on Friday. The stock has a market capitalization of $544.40 million, a PE ratio of 18.39 and a beta of 0.49. National Research Co. has a 1-year low of $20.41 and a 1-year high of $47.25. The business has a 50 day simple moving average of $22.95 and a two-hundred day simple moving average of $30.44. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.41 and a quick ratio of 0.41.
National Research Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Friday, September 27th. National Research’s payout ratio is 38.71%.
About National Research
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Recommended Stories
- Five stocks we like better than National Research
- What is a Special Dividend?
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Dell Can Continue Winning in AI and Beyond
- Market Cap Calculator: How to Calculate Market Cap
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.